WSR 10-15-039



(Medicaid Purchasing Administration)

[ Filed July 13, 2010, 12:05 p.m. ]

Subject of Possible Rule Making: New sections to chapter 388-530 WAC, Prescription drugs (outpatient); chapter 388-531 WAC, Physician-related services; and other related rules as appropriate.

Statutes Authorizing the Agency to Adopt Rules on this Subject: RCW 74.08.090.

Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: To allow for reimbursement for antihemophilia products such as clotting factors and/or anti-inhibitors related to treatment of congenital bleeding disorders for fee-for-service clients. Through one or more designated contractors, the department's goal is to provide improved patient monitoring and care coordination and achieve high quality and efficient delivery of medically necessary antihemophilia agents, related products, and supplies.

Process for Developing New Rule: DSHS welcomes the public to take part in developing the rules. Anyone interested should contact the staff person identified below. At a later date, DSHS will file a proposal with the office of the code reviser with a notice of proposed rule making. A copy of the proposal will be sent to everyone on the mailing list and to anyone who requests a copy.

Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Wendy L. Boedigheimer, Rules Program Manager, P.O. Box 45504, Olympia, WA 98504-5504, phone (360) 725-1306, fax (360) 586-9727, TTY (800) 848-5429, e-mail

July 13, 2010

Katherine I. Vasquez

Rules Coordinator

Washington State Code Reviser's Office